default author photo

Amir Baghbanzadeh

Tabriz University of Medical Sciences

Tabriz

Iran

  • Tabriz University of Medical Sciences

SCHOLARLY PAPERS

2

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Targeting Pd-L1 Combined with Paclitaxel Hampers Gastric Cancer Progression by Modulating Cell Proliferation, Apoptosis, and Migration

Number of pages: 24 Posted: 23 Jul 2024
Elaheh Zafari, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Leili Aghebati Maleki, Elham Baghbani, Sahar Safaei, Nadia Allahyarzadeh Khiabani, Parya Divsalar, Souzan Najafi and Behzad Baradaran
Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences and Tabriz University of Medical Sciences - Immunology Research Center
Downloads 49 (1,074,648)

Abstract:

Loading...

gastric cancer, paclitaxel, PD-L1-siRNA, Combination Therapy

2.

Dual Silencing of Tumor-Intrinsic VISTA and CTLA-4 Stimulates T-Cell Mediated Immune Responses and Inhibits MCF7 Breast Cancer Development

Number of pages: 25 Posted: 10 Oct 2023
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, Amir Baghbanzadeh, Tohid Kazemi, Ahad Mokhtarzadeh, Mahdi Jafarlou, Mohammad Amin Doustvandi and Behzad Baradaran
Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences - Immunology Research Center and Tabriz University of Medical Sciences - Immunology Research Center
Downloads 48 (1,086,013)

Abstract:

Loading...

Breast cancer, Inhibitory immune checkpoint, CTLA-4, VISTA, Immunotherapy